Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
|
|
8.
|
ADAM9 promotes lung cancer metastases to brain by a plasminogen activator-based pathway. [electronic resource] by
- Lin, Chen-Yuan
- Chen, Hung-Jen
- Huang, Cheng-Chung
- Lai, Liang-Chuan
- Lu, Tzu-Pin
- Tseng, Guan-Chin
- Kuo, Ting-Ting
- Kuok, Qian-Yu
- Hsu, Jennifer L
- Sung, Shian-Ying
- Hung, Mien-Chie
- Sher, Yuh-Pyng
Producer: 20150120
In:
Cancer research vol. 74
Availability: No items available.
|
|
9.
|
ADAM9 enhances CDCP1 by inhibiting miR-1 through EGFR signaling activation in lung cancer metastasis. [electronic resource] by
- Chiu, Kuo-Liang
- Lin, Yu-Sen
- Kuo, Ting-Ting
- Lo, Chia-Chien
- Huang, Yu-Kai
- Chang, Hsien-Fang
- Chuang, Eric Y
- Lin, Ching-Chan
- Cheng, Wei-Chung
- Liu, Yen-Nien
- Lai, Liang-Chuan
- Sher, Yuh-Pyng
Producer: 20180423
In:
Oncotarget vol. 8
Availability: No items available.
|
|
10.
|
ADAM9 promotes lung cancer progression through vascular remodeling by VEGFA, ANGPT2, and PLAT. [electronic resource] by
- Lin, Chen-Yuan
- Cho, Chia-Fong
- Bai, Shih-Ting
- Liu, Jing-Pei
- Kuo, Ting-Ting
- Wang, Li-Ju
- Lin, Yu-Sen
- Lin, Ching-Chan
- Lai, Liang-Chuan
- Lu, Tzu-Pin
- Hsieh, Chih-Ying
- Chu, Chin-Nan
- Cheng, Da-Chuan
- Sher, Yuh-Pyng
Producer: 20190708
In:
Scientific reports vol. 7
Availability: No items available.
|